| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| afamidis (Fx1006A);Tafamidis free acid;PF-06291826(Tafamidis);TafaMidis;Fx 1006; |
Tafamidis ；他發(fā)米帝司甲葡胺;他發(fā)米帝司;氯苯唑酸;2-(3,5-二氯苯基)-6-苯并惡唑甲酸;他法米迪 |
594839-88-0 |
詳細
|
| Trametinib free base;Mekinist trametinib;Trametinib (GSK1120212,JTP 74057);Trametinib, >=98%;CS-30;Trametinib Impurity;100836 |
曲美替尼；曲美替尼游離堿;曲美替尼、GSK1120212;曲美替尼1;MEK抑制劑(TRAMETINIB) |
871700-17-3 |
詳細
|
| TG101348; TG 101348; TG-101348; SAR302503; SAR-302503; SAR 302503; FEDRATINIB.;TG101348(Fedratinib);CS-57;TG-101348; TG 101348; |
fedratinib；JAK2抑制劑(TG-101348);費曲替尼;菲卓替尼;化合物FEDRATINIB; |
936091-26-8 |
詳細
|
| ETC-1002;Bempedoic Acid;ETC-1002 (ESP 55016);ESP 55016;ETC-1002(BEMPEDOIC ACID);CS-1544;Bempedoic Acid(ETC-1002;Bempedoate |
貝派地酸；8-羥基-2,2,14,14-四甲基十五烷二酸;貝派度酸API;8-羥基-2,2,14,14-四甲基Chemicalbook十五烷二酸(貝派度酸);苯丙醚酸;ETC-1002游離態(tài);貝派地酸API;ETC-1002(貝派地酸) |
738606-46-7 |
詳細
|
| ABT 492 MegluMine;ABT492 MegluMine;ABT-492 MegluMine;Delafloxacin (MegluMine) |
德拉沙星葡甲胺鹽；德拉沙星N-甲基葡萄糖胺鹽;德拉沙星葡甲胺鹽;地拉沙星葡甲胺;德拉沙星葡甲胺; |
352458-37-8 |
詳細
|
| Linezolid-13C-d3;Acetamide, N-[[(5S)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]- (9CI); |
利奈唑胺；雷奈佐利(利奈唑胺);利奈唑胺(游離);嗎啉惡酮(標準品);雷奈佐利;利奈唑胺 |
165800-03-3 |
詳細
|
| Lifitegrast-d4;Lifitegrast Impurity;lifitegrast;Lifitegrast, SAR 1118 |
立他司特；利菲司特;立他斯特雜質(zhì); |
1025967-78-5 |
詳細
|
| Cinacalcet Hydrochloride;N-[(1R)-1-naphthalen-1-ylethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine hydrochloride; |
鹽酸甲狀旁腺激素；RAC西那卡塞-D3(甲基-D3)安泰樂;鹽酸西那卡塞(鹽酸甲狀旁腺激素);西那卡賽鹽酸鹽; |
364782-34-3 |
詳細
|
| Empagliflozin(W.S);Empaglifloin;Empagliflozin API;BI-10773;BI 10773;BI10773;CS-798;EMPAGLIFLBZIN;EMpagliflozin;BI-10773 |
依帕列凈；艾格列凈;(1S)-1,5-脫水-1-(4-氯-3-{4-[(3S)-四氫呋喃-3-基氧基]芐基}苯基)-D-葡萄糖醇; |
864070-44-0 |
詳細
|
| DFSX-2;Ethyl1-(6-amino-3,5-difluoropyridin-2-yl)-6-fluoro-7-(3-(isobutyryloxy)azetidin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate; |
德拉沙星;1-(6-氨基-3,5-二氟吡啶-2-基)-6-氟-7-[3-(異丁酰氧基)氮雜環(huán)丁烷-1-基]-4-氧代-1,4-二氫喹啉-3-甲酸乙酯; |
442526-91-2 |
詳細
|
| Vonoprazan;1-[5-(2-Fluorophenyl)-1-[(pyridin-3-yl)sulfonyl]-1H-pyrrol-3-yl]-N-methylmethanamine; |
沃諾拉贊；富馬酸沃諾他贊;沃諾拉贊間氟異構(gòu)體;凡諾帕胺;沃諾拉贊; |
881681-00-1 |
詳細
|
| NS-304;Selexipag;ACT-293987;NS-304(Selexipag);Selexipag API |
賽樂西帕；司來帕格;塞萊西帕格雜質(zhì);2-(4-((5,6-二苯基吡嗪-2-基)(異丙基)氨基)丁氧基)乙酸酯 |
475086-01-2 |
詳細
|
| Ticagrelor, >=98%;Ticagrelo;Ticargrelor;Brilinta;Possia;Ticagrelor and intermediates;Ticagrelor Standards |
替卡格雷；替格瑞洛;替卡格雷,替格雷洛,替格瑞洛;替卡格雷及中間體;替卡格雷標準品;替格瑞洛/替卡格雷;替格瑞洛;提卡格雷 |
274693-27-5 |
詳細
|
| AZILSARTAN;2-Ethoxy-1-[[2'-(4,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylic acid Azilsartan; |
阿齊沙坦；阿齊沙坦酯雜質(zhì)A;阿齊沙坦(降壓藥);阿齊沙坦INT E;阿奇沙坦 10G;阿齊沙坦, ≥98% (HPLC);阿齊沙坦原料藥;阿齊沙坦(阿齊主鏈) |
147403-03-0 |
詳細
|
| Mirabegron;N-(4-(2-(2-hydroxy-2-phenylethylamino)ethyl)phenyl)-2-(2-aminothiazol-4-yl)acetamide;YM 178;Mirabegron(YM 178) |
米拉貝隆；米拉貝隆雜質(zhì)B;2-氨基-N-[4-[2-[[(2R)-2-羥基-2-苯基乙基]氨基]乙基]苯基]-4-噻唑乙酰胺;米拉貝隆API; |
223673-61-8 |
詳細
|
| Abemaciclib, >=98%;Abemaciclib;abemaciclib(CDK 4/6 inhibitor);Abemaciclib (LY2835219);Bemaciclib(LY2835219, abemaciclib);CDK4/6 dual inhibitor; |
阿貝西利；阿貝昔利布;?，斘髂?阿貝西尼;N-(5-((4-乙基哌嗪-1-基)甲基)吡啶-2-基)-5-氟-4-(4-氟-1-異丙基-2-甲基-1H-苯并[D]咪唑-6-基)嘧啶-2-胺; |
1231929-97-7 |
詳細
|
| Trilaciclib |
|
|
詳細
|
| LEE011, >=98%;7-CYCLOPENTYL-2-(5-PIPERAZIN-1-YL-PYRIDIN-2-YLAMINO)-7H-PYRROLO[2,3-D]PYRIMIDINE-6-CARBOXYLIC ACID DIMETHYLAMIDE;LEE-011, Ribociclib; |
瑞博西利；LEE011 瑞柏司可里布 50MG;瑞柏司可里布;LEE011 瑞柏司可里布;7-環(huán)戊基-N,N-二甲基-2-[[5-(1-哌嗪基)-2-吡啶基]氨基]-7H-吡咯并[2,3-D]嘧啶-6-甲酰胺; |
1211441-98-3 |
詳細
|
| DAPAGLIFLOZIN;(1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol;Dapagliflozin propanediol;BMS-512148-05;Dapagliflozin S1548 Selleck;DAPAGLIFLOZIN BASE;Daglican;Dapagliflozi |
達格列凈；達格列嗪 50G;達格列凈 (游離堿);達格列凈 / (1S)-1,5-脫水-1-C-[4-氯-3-[(4-乙氧基苯基)甲基]苯基]-D-葡萄糖醇;達格列凈(無水);達帕格列佛嗪雜質(zhì) |
461432-26-8 |
詳細
|
| ApreMilast,CC-10004;brand name: Otezla.;CC10004; CC-10004; CC 10004; APREMILAST; BRAND NAME: OTEZLA.; |
阿普斯特；匹米斯特;(+)-2-[1-(3-乙氧基-4-甲氧基苯基)-2-甲基磺酰乙基]-4-乙酰氨基異吲哚啉-Chemicalbook1,3-二酮;阿普斯特(APREMILAST);阿普司特;APREMILASTCC-10004阿普斯特 |
608141-41-9 |
詳細
|
| Finerenone (BAY 94-8862);(4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide;BAY 94-8862;BAY948862; |
非奈利酮；化合物FINERENONE;(4S)-4-(4-氰基-2-甲氧基苯基)-5-乙氧基-1,4-二氫-2,8-二甲基-1,6-萘啶-3-甲酰胺;FINERENONE 非萘立酮 BAY 94-8862 |
1050477-31-0 |
詳細
|
| PF07321332(Paxlovid);nirmatrelvir;Nirmatrelvir (PF-07321332);PF-07321332-005; |
帕羅韋德；PAXLOVID;帕克洛維德;帕羅韋德試劑;PF-07321333; |
2628280-40-8 |
詳細
|
| 0DM021;BAY-1841788;ODM-021;0DM021;ODM 021;ODM 021;ODM-021;ODM-201 |
達洛魯胺；達羅魯塔米德;達洛魯胺,達羅他胺;多拉米胺;N-((S)-1-(3-(3-氯-4-氰基苯基)-1H-吡唑-1-基)丙-2-基)-5-(1-羥乙基)-1H-吡唑-3-甲酰胺 |
1297538-32-9 |
詳細
|
| Exatecan;DX 8951;CS-147;Exatecan Impurity; |
依喜替康；依喜替康雜質(zhì);伊立替康雜質(zhì)36;伊喜替康 |
171335-80-1 |
詳細
|
| AHU-377,149709-62-6;AHU-37;AHU377; AHU 377; SACUBITRIL |
沙庫巴曲；CZ696原研900-04;塞克比曲纈沙坦復(fù)合物;AHU-377(鈉鹽); |
149709-62-6 |
詳細
|
| ROFLUMILAST;3-(Cyclopropylmethoxy)-N-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy)benzamide;B 9302-107;BY 217;BYK 20869;Daxas; |
羅氟司特；/ROFLUMILAST/3-(環(huán)丙甲氧基)-N-(3,5-二氯-4-吡啶基)-4-(二氟甲氧基)苯甲酰胺;達菲寧Chemicalbook;3-(環(huán)丙基甲氧基)-N-(3,5-二氯-4-吡啶基)-4-(二氟甲氧基)苯甲酰胺; |
162401-32-3 |
詳細
|
| Etoricoxib Solution, 100ppm;Etoricoxib (MK-663;Etoricoxib Tablets;Etoricoxib(5-chloro-6'-Methyl-3-(4-(Methylsulfonyl)phenyl)-2,3'-bipyridine; |
依托考昔；2,3'-聯(lián)吡啶, 5-氯-6'-甲基-3-[4-(甲基磺?；?苯基]-;依托考西;依他昔布 |
202409-33-4 |
詳細
|
| Trilaciclib |
曲拉西利；G1T28 ; G1T-28 ; G1T 28 ; TRILACICLIB.;曲拉西利;骨髓保護劑;化合物 T13202L |
1374743-00-6 |
詳細
|
| PA-824 |
(S)-6,7-二氫-2-硝基-6-[[4-(三氟甲氧基)苯基]甲氧基]-5H-咪唑并[2,1-B][1,3]惡嗪 |
187235-37-6 |
詳細
|
| Resmetirom (MGL-3196,VIA-3196);MGL-3196; MGL 3196; MGL3196; VIA-3196; VIA3196; VIA-3196;VIA3196;VIA-3196; |
Resmetirom；RESMETIROM(MGL-3196);MGL-3196游離態(tài);化合物MGL3196; |
920509-32-6 |
詳細
|
| TAK-788 |
莫博替尼 |
1847461-43-1 |
詳細
|
| Aripiprazole |
阿立哌唑 |
129722-12-9 |
詳細
|
| Brexpiprazole |
依匹哌唑 |
913611-97-9 |
詳細
|
| CP-690550(Tasocitinib,CP690550);CP 690550(Tasocitinib);Tasocitinib;3-((3R,4R)-4-Methyl-3-(Me...;Tasocitinib (CP 690550) |
托法替尼；3-((3R,4R)-4-甲基-3-(甲基(7H-吡咯[2,3-D]嘧啶-4-基)胺基)哌啶-1-基)-3-氧代丙腈; |
477600-75-2 |
詳細
|
| BENZIMIDAVIR |
馬立巴韋；BENZIMIDAVIR 苯并咪唑核苷;苯并咪唑核苷; |
176161-24-3 |
詳細
|
| 1,3,5-Triazine-2,4-diamine,1,6-dihydro-N,N,6-trimethyl-,(+)-(9CI);IMegliMin;EMD 387008;R-IMegliMin;EMD 387008/R-Imeglimin;EMD 387008 (R-IMEGLIMIN) HCL; |
伊美格列明；IMEGLIMIN游離態(tài);(+)-(9CI)-1,6-二氫-N,N,6-三甲基-1,3,5-三嗪-2,4-二胺;伊美格列明;依格列明;(2S)Chemicalbook-N6,N6,2-三甲基-1,2-二氫-1,3,5-三嗪-4,6-二胺;IMEGLIMIN(依美格列);依格列明/伊美格列明;化合物T22860 |
775351-65-0 |
詳細
|
| linagliptin;8-[(3R)-3-Amino-1-piperidinyl]-7-(2-butynyl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione; |
利拉利汀；LINAGLIPTIN利拉利汀(BI-1356);利格利汀;歐唐寧;利拉利汀 1KG;利拉利汀API;利納利汀;利拉利汀原料藥;利格列汀 |
668270-12-0 |
詳細
|
| Trelagliptin(syr472);Benzonitrile,2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-4-flChemicalbookuoro-;Trelagliptin(R)-2-[[6-(3-Aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl]methyl]-4-fluorobenzonitrile; |
曲格列汀；曲格列汀1;曲格列汀-INT E;曲格列汀;(R)-2-((6-(1-(3-胺哌啶基)-3-甲基-2,4-二氧雜-3,4-二氫吡啶基-1-(2H)-基)甲基)-4-氟苯甲氰 |
865759-25-7 |
詳細
|
| SPRYCEL;BMS354825;DASATINIB (BMS 354825);CS-1968; |
達沙替尼；5-噻唑甲酰胺,N-(2-氯-6-甲基苯基)-2-[[6-[4-(2-羥基乙基)-1-哌嗪基]-2-甲基-4-嘧啶基]Chemicalbook氨基]-;DASA錫IB;達沙替尼無水物(N-6晶型)大粒徑(D50=30-60);達沙替尼無水物(N-6晶型)粉末狀; |
302962-49-8 |
詳細
|
| Sorafenib free base for research;Sorafenib Free Base;Forafenib;Sorafenib free base(Bay43-9006);nexavar,sorafenib;BAY43-9006; NEXAVAR;Nexavar;Sorafenib-d4 |
索拉非尼；索拉非尼及中間體;所拉菲尼;SORAFENIB TOSYLATE 索拉非尼;RAF抑制劑;4-{4-[3-(4-氯-3-三氟甲基苯基)酰脲]苯氧基}吡啶-2-甲酰胺;甲苯磺酸索拉替尼(替尼類);索拉替尼 |
284461-73-0 |
詳細
|
| AZD2281(olaparib);4-(3-(1-(cyclopropanecarbonyl)piperazine-4-carbonyl)-4-fluorobenzyl)phthalazin-1(2H)-one |
奧拉帕尼；PARP 抑制劑;4-[4-氟-3-(哌嗪-1-環(huán)丙基羰基)芐 基]-2H-酞嗪-1-酮; |
763113-22-0 |
詳細
|
| TAK-385;Relugolix;Altropane;TKA-385 Relugolix; |
瑞盧戈利；1-(4-(1-(2,6-二氟芐基)-5-((二甲基氨基)甲基)-3-(6-甲氧基噠嗪-3-基)-2,4-二氧-1,2,3,4-四氫噻吩并[2,3-D]嘧啶-6-基)苯基)-3-甲氧基脲, |
737789-87-6 |
詳細
|
| entrecitinib;Entrectinib(RXDX-101) |
恩曲替尼；恩曲替尼;TRK/ROS1/ALK抑制劑;恩曲替尼RXDX-101;RXDX-101恩曲替尼;NVP-LGK974, WNT974 |
1108743-60-7 |
詳細
|
| Solriamfetol;(S)-2-amino-3-phenylpropyl carbamate hydrochloride |
solriamfetol；索利氨酯 |
561069-23-6 |
詳細
|
| KPT-330;(2Z)-3-[3-[3,5-Bis(trifluoromethyl)phenyl]-1H-1,2,4-triazol-1-yl]-2-propenoic acid 2-(2-pyrazinyl)hydrazide;Selinexor; |
Selinexor；塞利尼索;塞靈克斯;(Z)-3-(3-(3,5-雙(三氟甲基)苯基)-1H-1,2,4-三唑-1-基)-N'-(吡嗪-2-基)丙烯酰肼 |
1393477-72-9 |
詳細
|
| Nemorexant;Methanone, [(2S)-2-(6-chloro-7-methyl-1H-benzimidazol-2-yl)-2-methyl-1-pyrrolidinyl][5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl]-;Daridorexant |
奈莫雷生;達利多雷生 |
1505484-82-1 |
詳細
|
| ACT 064992;ACT-064992;ACT-064992 / ACT064992;Macitentan, >=99%; |
馬西替坦；艾德拉尼中間體1;馬西;馬昔替坦;馬西替坦 API;麥西騰坦 |
441798-33-0 |
詳細
|
| Carbamic acid, (4,6-diamino-2-(1-((2-fluorophenyl)methyl)-1H-pyrazolo(3,4-B)pyridin-3-yl)-5-pyrimidinyl)methyl-, methyl ester;Riociguat (BAY 63-2521);Riocguat;CS-718;Riociguat, BZY 632521 |
利奧西胍；磺達肝癸鈉中間體I(A-8);利奧西呱,BAY 63-2521;利奧西呱雜質(zhì)(A-D);利奧西呱雜質(zhì)D;利奧西呱(API);氘代鹽酸利莫那班;利奧西呱 |
625115-55-1 |
詳細
|
| Regorafenib;BAY 73-4506;4-[4-({[4-Chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-N-methylpyridine-2-carboxamide; |
瑞戈非尼；瑞格菲尼無水物;瑞格菲尼及中間體;BAY 73-4506/ 瑞格非尼/ 4-[4-({[4-氯-3-(三氟甲基)苯基]氨基甲酰}氨基)-3-氟苯氧基]-N-甲基吡啶-2-甲酰胺;瑞格菲尼雜質(zhì); |
755037-03-7 |
詳細
|
| Carbozantinib;Cabozantinib(XL184Malate);Cabozantinib (XL184, BMS-907351); |
卡博替尼；XL184(博卡替尼);XL-184(卡博替尼);卡博替尼堿;卡博替尼 100MG; |
849217-68-1 |
詳細
|
| AV951 (KRN951, Tivozanib) (stopped use since the patent issue);AV-951; KRN951; AV 951;AV951;CS-8; |
替沃扎尼；N-[2-氯-4-[(6,7-二甲氧基-4-喹啉基)氧基]苯基]-N'-(5-甲基-3-異惡唑基)脲; |
475108-18-0 |
詳細
|
| E7080;LENVATINIB;E7080 (Lenvatinib);Lenvatinib (E7080); |
樂伐替尼；樂伐替尼 4-[3-氯-4-(環(huán)丙基氨基羰基)氨基苯氧基]-7-甲氧基-6-喹啉甲酰胺;倫瓦替尼;樂伐替尼游離堿;樂伐替尼 LENVATINIB;侖伐替尼 |
417716-92-8 |
詳細
|
| LOXO-101;CS-2322;LOXO101;LOXO 101;LOXO-101,LAROTRECTINIB,ARRY-470 (LAROTRECTINIB SULFATE CAS:1223405-08-0); |
拉羅替尼；拉洛替尼;拉羅托西尼雜質(zhì);拉羅特里尼雜質(zhì);原肌球蛋白受體激酶抑制劑(TRK抑制劑)(LOXO-101); |
1223403-58-4 |
詳細
|
| INTEDANIB BASE;Nintedanib;Nintedanib (BIBF 1120);Nintedanib/Intedanib/Vargatef;BIBF 1120; VARGATEF; INTEDANIB;INTEDANIB BASE;Intedanib Vargatef;Nintedanib-016;100837 |
尼達尼布；(3Z)-2,3-二氫-3-[[[4-[甲基[2-(4-甲基-1-哌嗪基)乙酰]氨基]苯基]氨基]苯亞甲基]-2-氧代-1H-吲哚-6-甲酸甲酯;尼達尼布乙烷磺酸鹽;尼達尼布雜質(zhì)(A-D) |
656247-17-5 |
詳細
|
| AF-802;CH-5424802/RG-7853;Alectinib (CH5424802);AF 802; AF-802; AF802; CH5424802; CH5424802; CH 5424802; RO5424802; RO 5424802; RO5424802, ALECTINIB; |
艾樂替尼 |
1256580-46-7 |
詳細
|
| n-methyl-3-(2-methylphenoxy)benzenepropanamine;(r)-tomoxetine;Tomoxetine;TomoxetineHcl; |
托莫西??；(R)-托莫西汀;(R)-N-甲基-3-(2-甲基苯氧)-3-苯丙胺;托莫西汀;托莫西汀雜質(zhì)F;托莫西汀雜質(zhì)G;托莫西汀雜質(zhì)B EP標準品 |
83015-26-3 |
詳細
|
| LasMiditan;2,4,6-trifluoro-N-(6-(1-Methylpiperidine-4-carbonyl)pyridin-2-yl)benzaMide;COL-144; LY573144;CS-2381;COL-144; LY-573144;COL144; LY 573144; |
拉米地坦；拉米迪坦;2,4,6-三氟-CHEMICALBOOKN-[6-[(1-甲基-4-哌啶基)羰基]-2-吡啶基]苯甲酰胺;拉米地坦/拉斯米地坦 |
439239-90-4 |
詳細
|
| N-(2-Acetamido)iminodiacetic acid |
乙酰氨基亞胺乙酸 |
26239-55-4 |
詳細
|
| 1-(4-Nitrophenyl)acetone;2-Propanone,1-(4-nitrophenyl)-; |
4-硝基苯丙酮；4-硝基苯丙酮, |
5332-96-7 |
詳細
|
| 7-Chloro-[1,2,4]triazolo[1,5-a]pyridine |
7-氯-[1,2,4]三唑并[1,5-A]吡啶 |
1427452-48-9 |
詳細
|
| ALOGLIPTIN(ALOG
LIPTINE, ALOGLIPTINA) |
阿格列?。话⒙謇?曲格列汀雜質(zhì)T;2-[[6-[(3R)-3-氨基-1-哌啶基]-3,4-二氫-3-甲基-2,4-二氧Chemicalbook代-1(2H)-嘧啶基]甲基]苯甲腈(阿格列汀,又名:阿洛利停);苯甲酸阿格列汀原料藥;苯甲酸阿格列汀中間體2 |
850649-61-5 |
詳細
|
| ISOPROPYLUREA |
異丙基脲 |
691-60-1 |
詳細
|
| Irbinitinib;Irbinitinib(ARRY380);Irbinitinib (ARRY-380,Tucatinib,ONT 380);IRBINITINIB (ARRY-380; ONT-380) |
妥卡替尼；6-[5-[[[2-(甲磺酰基)乙基]氨基];HER2抑制劑(IRBINITINIB);中文名:妥卡替尼英文名:IRBINITINIB (ARRY-380); |
937263-43-9 |
詳細
|
| Momelotinib |
莫洛替尼 |
1056634-68-4 |
詳細
|
| sparsentan |
司帕生坦 |
254740-64-2 |
詳細
|
| AZD-9291 |
邁瑞替尼 |
1421373-65-0 |
詳細
|
| Masitinib |
馬賽替尼 |
790299-79-5 |
詳細
|
| Undecylenoyl phenylalanine |
十一碳烯?；奖彼?/td>
| 175357-18-3 |
詳細
|
| reproxalap |
REPROXALAP |
916056-79-6 |
詳細
|
| vericiguat |
維利西呱 |
1350653-20-1 |
詳細
|
| aprocitentan |
阿西替坦 |
1103522-45-7 |
詳細
|
| Trilaciclib |
曲拉西利 |
1374743-00-6 |
詳細
|
| TAK-788 |
莫博替尼 |
1847461-43-1 |
詳細
|
| Aripiprazole |
阿立哌唑 |
129722-12-9 |
詳細
|
| Brexpiprazole |
依匹哌唑 |
913611-97-9 |
詳細
|
| VX-770 |
依伐卡托 |
873054-44-5 |
詳細
|
| Resmetirom (MGL-3196,VIA-3196);MGL-3196; MGL 3196; MGL3196; VIA-3196; VIA3196; VIA-3196;VIA3196;VIA-3196; |
Resmetirom；RESMETIROM(MGL-3196);MGL-3196游離態(tài);化合物MGL3196; |
920509-32-6 |
詳細
|
| 4-Aminopiperidine-4-carboxylic acid |
4-氨基哌啶-4-羧酸 |
40951-39-1 |
詳細
|
| Salcaprozate Sodium |
8-（2-羥基苯甲酰胺基）辛酸鈉 |
203787-91-1 |
詳細
|
| N-Desmethyl lmatinib |
N-去甲基伊馬替尼 |
404844-02-6 |
詳細
|
| Methyl Green |
甲基綠 |
7114-03-6 |
詳細
|
| 2,6-Dichlorophenolindophenol sodium salt xhydrate |
2,6-二氯靛酚 鈉鹽 水合物 |
1266615-56-8 |
詳細
|
| Morpholine hydrochloride |
嗎啡啉鹽酸鹽 |
10024-89-2 |
詳細
|
| Tetrabromophenol blue |
四溴酚藍 |
4430-25-5 |
詳細
|
| 5',5''-Dinitro-3',3''-diiodo-3,4,5,6-trtrabromophenol-sulfonephthalein |
5', 5''-二硝基-3', 3''-二碘基-3,4,5,6-四溴酚磺酞 |
145551-16-2 |
詳細
|
| Triisopropanolamine Borate |
三異丙醇胺環(huán)硼酸鹽 |
101-00-8 |
詳細
|
| Tri(4-morpholinyl)phosphine oxide |
三(4-嗎啉基)氧化膦 |
4441-12-7 |
詳細
|
| 1,2,3,4-tetrahydro-benzo[h]quinolin-3-ol hydrochloride |
1,2,3,4-四氫苯并喹啉-3-酚鹽酸鹽 |
73579-26-7 |
詳細
|
| 3-(N-tosyl-L-alanyloxy)-indole |
3-（N-對甲苯磺?；?L-丙氨酰氧基）-吲哚 |
75062-54-3 |
詳細
|
| 2,4-Dichlorobenzenediazonium tetrafluoroborate |
2,4二氯苯基重氮四氟硼酸鹽 |
21872-70-8 |
詳細
|
| 2-Methoxy-4-morpholinobenzenediazonium chloride zinc chloride double salt |
2-甲氧基-4-嗎啉基重氮苯氯化鋅鹽 |
67801-08-5 |
詳細
|
| 2,5,6-TRICHLORO-1H-BENZIMIDAZOLE |
2,5,6-三氯苯并咪唑 |
16865-11-5 |
詳細
|
| Ethyl Isocyanatoacetate |
異氰酰乙酸乙酯 |
2949-22-6 |
詳細
|
| 6-CHLORO-3-(1-METHYLETHYL)-2,4-(1H,3H)-PYRIMIDINEDIONE |
6-氯-3-異丙基嘧啶-2,4(1H,3H)-二酮 |
887581-47-7 |
詳細
|
| N(4)-hydroxycytidine |
N-羥基胞苷 |
3258-02-4 |
詳細
|
| 4'-AMINOPROPIOPHENONE |
4-胺基丙苯酮 |
70-69-9 |
詳細
|
| Pirtobrutinib |
LOXO-305 |
2101700-15-4 |
詳細
|
| Menaquinone 7 |
維生素K2（35） |
2124-57-4 |
詳細
|
| ensifentrine |
恩塞芬汀 |
1884461-72-6 |
詳細
|
| POLY(VINYL METHYL ETHER) |
聚乙烯甲基醚、聚乙烯基甲醚 |
9003-09-3 |
詳細
|